1. Home
  2. ELDN vs TP Comparison

ELDN vs TP Comparison

Compare ELDN & TP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.97

Market Cap

219.4M

Sector

Health Care

ML Signal

HOLD

TP

Ticketplus Ltd.

SELL

Current Price

$8.34

Market Cap

246.4M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
ELDN
TP
Founded
2004
2014
Country
United States
Chile
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
219.4M
246.4M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
ELDN
TP
Price
$1.97
$8.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$9.00
★ $14.50
AVG Volume (30 Days)
★ 918.4K
22.7K
Earning Date
11-12-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 30.67
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$74.96
Revenue Next Year
N/A
$23.91
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$6.10
52 Week High
$4.49
$12.14

Technical Indicators

Market Signals
Indicator
ELDN
TP
Relative Strength Index (RSI) 35.64 50.93
Support Level N/A $7.05
Resistance Level $3.14 $9.58
Average True Range (ATR) 0.27 0.76
MACD -0.07 0.02
Stochastic Oscillator 3.83 62.86

Price Performance

Historical Comparison
ELDN
TP

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: